NIH funds consortium to speed TB treatment development
July 11, 2024
July 11, 2024
ITHACA, New York, July 11 -- Cornell University issued the following news:
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis (TB).
Investigators at the University of California, San Francisco; Johns Hopkins Medicine; and Vanderbilt Univers . . .
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis (TB).
Investigators at the University of California, San Francisco; Johns Hopkins Medicine; and Vanderbilt Univers . . .